Provided by Tiger Trade Technology Pte. Ltd.

Carlisle

339.93
+0.06000.02%
Post-market: 339.930.00000.00%16:10 EDT
Volume:350.75K
Turnover:119.15M
Market Cap:13.90B
PE:19.86
High:346.99
Open:343.43
Low:334.15
Close:339.87
52wk High:435.92
52wk Low:293.43
Shares:40.88M
Float Shares:40.33M
Volume Ratio:0.70
T/O Rate:0.87%
Dividend:4.20
Dividend Rate:1.24%
EPS(TTM):17.12
EPS(LYR):17.12
ROE:34.87%
ROA:10.38%
PB:7.74
PE(LYR):19.86

Loading ...

Carlisle posts FY2025 operating income of USD 1,002.5 million, down 12.3%

Reuters
·
Feb 14

Stephen Schwar, Vice Chair of CCM, Reports Sale of Carlisle Companies Inc. Common Shares

Reuters
·
Feb 14

CSL (ASX:CSL) Valuation After Profit Slump CEO Exit And Expanded Share Buyback Program

Simply Wall St.
·
Feb 13

Weekly Earnings Wrap: CBA, CSL, MQG and more

Morning Star AU
·
Feb 13

Canaccord Genuity Keeps Their Buy Rating on CSL (CMXHF)

TIPRANKS
·
Feb 12

Top Carlisle Executives Quietly Cash Out Millions in Insider Stock Sales

TIPRANKS
·
Feb 12

CSL (CMXHF) Gets a Buy from Morgans

TIPRANKS
·
Feb 12

CSL (CMXHF) Gets a Hold from Ord Minnett

TIPRANKS
·
Feb 12

Bell Potter Reaffirms Their Hold Rating on CSL (CMXHF)

TIPRANKS
·
Feb 12

Carlisle Companies CEO D. Christian Koch Reports Disposal of Common Shares

Reuters
·
Feb 12

Carlisle Companies VP Sustainability David W. Smith Reports Disposal of Common Shares

Reuters
·
Feb 12

CSL downgraded to Sector Perform from Outperform at RBC Capital

TIPRANKS
·
Feb 11

CSL's Fiscal H1 EBIT Boosted by Cost Reductions, Jarden Says

MT Newswires Live
·
Feb 11

CSL Discloses Final Director Interest Notice as Paul McKenzie Steps Down

TIPRANKS
·
Feb 11

CSL Shares Fall 6.5% on Earnings Miss, Surprise CEO Change

Dow Jones
·
Feb 11

Update: CSL Posts Lower Fiscal H1 Underlying Earnings, Revenue; Reaffirms Fiscal 2026 Outlook; Shares Hit Eight-Year Low

MT Newswires Live
·
Feb 11

Analysts Offer Insights on Healthcare Companies: CSL (OtherCMXHF) and Cardinal Health (CAH)

TIPRANKS
·
Feb 11

Former 'market-darling' CSL dumps CEO as it reports results

Switzer
·
Feb 11

CSL loses $10 billion in Trump vaccine crossfire

The West Australian
·
Feb 11

CSL Posts Fiscal H1 Underlying EPS of $4.03 Vs FactSet Estimate of $4.12, Revenue of $8.33 Billion Vs FactSet Estimate of $8.49 Billion

MT Newswires Live
·
Feb 11